United Microelectronics Corporation heads into September with a striking divergence: the stock has climbed 6% in a week and nearly 10% in a month, yet the cost to borrow shares has tripled over the same period — a tension between equity momentum and a quietly shifting lending market.
The borrowing story is the most interesting development right now. Cost to borrow has surged nearly 200% over the past month, hitting 1.76% on September 1 from a low of around 0.34% in late July. That's a sharp move in absolute terms, even if the rate remains modest by global standards. The speed of the rise matters: CTB doubled just in the final two days of August alone. Availability remains extremely loose — over 2,900% of current short interest, meaning there is roughly 29 shares available for every one already borrowed — so the borrow market is far from stressed. But the CTB spike alongside a rising availability figure suggests increased demand for borrows is arriving faster than supply is tightening. Short interest itself is a non-event at this level. With availability this deep, the lending dynamic reads as a footnote rather than a warning sign.
The short score supports the same calm read on positioning. ORTEX's short score has been drifting gradually higher, now at 27.4 — up from 27.2 a week ago — but that steady creep is less a squeeze signal and more a reflection of the CTB move being absorbed by a deep pool of lendable stock. Among correlated TSEC peers, posted the strongest single-day gain at 4.9%, and added 7.4% on the week — broadly matching UMC's own move, suggesting the rally is sector-wide rather than stock-specific.
The Street is firmly in the bulls' corner. Thirteen analysts carry buy ratings against just four holds, with no sells on the register. The analyst recommendation differential ranks in the 99th percentile of the ORTEX universe — one of the strongest consensus tilts across all covered stocks. Valuation multiples have re-rated meaningfully over the past month: price-to-book has expanded by roughly 0.23 turns to 3.28x, and the earnings yield has risen to 6.0%. The PE has come in slightly over 30 days, now at 16.7x, suggesting earnings estimates have kept pace with — or slightly outrun — the share price. EV/EBITDA at 9.5x has compressed about one turn over the month, which is consistent with a market attributing less caution to the name than it did a month ago. The 90-day EPS momentum factor ranks in the 87th percentile, and the EPS surprise score at 89 reflects a track record of beating estimates. The forward earnings growth score (12-month YoY EPS increase) ranks in just the 7th percentile, however — a reminder that the bull case rests more on current profitability than on aggressive growth acceleration.
The most recent earnings context is worth carrying. Q2 results in late July sent the stock down 3% on the day, before recovering sharply — UMC gained 7.5% in the five sessions after that print. Management raised H2 guidance on strength in automotive and IoT segments, pointing to mid-single-digit sequential growth and customer front-loading ahead of expected capacity tightening. That guidance lift likely underpins much of the August rally. On the ownership side, BlackRock recently added over 20 million shares to reach a 7.75% stake, while Norges Bank added over 41 million shares as of June 30 — both moves pointing toward international institutions building exposure. The lone insider note is a CFO sale of 1.9 million shares in mid-July at TWD 154.89, representing a modest trimming from a higher level than today's TWD 132.5 close.
The next scheduled earnings event is October 28. Between now and then, the key variables to track are whether the CTB acceleration continues and how the availability pool responds, whether sector-wide TSEC semiconductor momentum holds its breadth into month-end, and whether the 90-day EPS momentum score continues to climb ahead of what management has flagged as a firmer second half.
See the live data behind this article on ORTEX.
Open 2303 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
